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Abstract 
Background: Bovine progressive degenerative myeloencephalopathy (Weaver syndrome) is a neurodegenerative 
disorder in Brown Swiss cattle that is characterized by progressive hind leg weakness and ataxia, while sensorium and 
spinal reflexes remain unaffected. Although the causal mutation has not been identified yet, an indirect genetic test 
based on six microsatellite markers and consequent exclusion of Weaver carriers from breeding have led to the com-
plete absence of new cases for over two decades. Evaluation of disease status by imputation of 41 diagnostic single 
nucleotide polymorphisms (SNPs) and a common haplotype published in 2013 identified several suspected carriers in 
the current breeding population, which suggests a higher frequency of the Weaver allele than anticipated. In order to 
prevent the reemergence of the disease, this study aimed at mapping the gene that underlies Weaver syndrome and 
thus at providing the basis for direct genetic testing and monitoring of today’s Braunvieh/Brown Swiss herds.
Results: Combined linkage/linkage disequilibrium mapping on Bos taurus chromosome (BTA) 4 based on Illumina 
Bovine SNP50 genotypes of 43 Weaver-affected, 31 Weaver carrier and 86 Weaver-free animals resulted in a maximum 
likelihood ratio test statistic value at position 49,812,384 bp. The confidence interval (0.853 Mb) determined by the 
2-LOD drop-off method was contained within a 1.72-Mb segment of extended homozygosity. Exploitation of whole-
genome sequence data from two official Weaver carriers and 1145 other bulls that were sequenced in Run4 of the 
1000 bull genomes project showed that only a non-synonymous SNP (rs800397662) within the PNPLA8 gene at posi-
tion 49,878,773 bp was concordant with the Weaver carrier status. Targeted SNP genotyping confirmed this SNP as a 
candidate causal mutation for Weaver syndrome. Genotyping for the candidate causal mutation in a random sample 
of 2334 current Braunvieh animals suggested a frequency of the Weaver allele of 0.26 %.
Conclusions: Through combined use of exhaustive sequencing data and SNP genotyping results, we were able to 
provide evidence that supports the non-synonymous mutation at position 49,878,773 bp as the most likely causal 
mutation for Weaver syndrome. Further studies are needed to uncover the exact mechanisms that underlie this 
syndrome.
© 2016 Kunz et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Since the first case report of a new autosomal recessive 
disorder in purebred Brown Swiss cattle was published 
in 1973 [1], efforts have been undertaken to identify 
the gene that causes bovine progressive degenerative 
myeloencephalopathy or the so-called Weaver syndrome. 
However, although the genetic mechanisms that under-
lie other heritable diseases in the Brown Swiss/Braunvieh 
breed [2–4] have been elucidated, the mutation that is 
responsible for Weaver syndrome remains unknown to 
date. The first symptoms of this disorder are observed 
at 5–8 months of age and include ataxia, hind leg weak-
ness and a weaving gait [5, 6]. Normal sensorium and spi-
nal reflexes are maintained throughout the course of the 
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disease while affected animals progressively lose control 
over their hind quarters until they become recumbent 
and have to be euthanized for animal welfare reasons [5, 
7]. The histopathological lesions are mainly observed in 
the white matter of the spinal cord and the highest con-
centration of lesions are observed in the cranial thoracic 
segment; the grey matter remains unaffected [8–10]. 
Degenerative changes comprise axonal swelling (sphe-
roids), disintegration of myelin sheaths and myelin loss 
as well as axonal atrophy to the point of complete loss 
and status spongiosus [8, 9, 11]. Similar alterations are 
observed in the pyramids and the inferior olivary nuclei, 
whereas those in the cerebellum consist of a reduced 
number of Purkinje cells [9].
This neurodegenerative disease originated in the 
United States and was introduced into Braunvieh herds 
in Canada [12] and Europe [13] through the use of 
American Brown Swiss semen for artificial insemina-
tion (AI), with cases reported in Switzerland [10], Ger-
many [5, 14], Italy [15] and Denmark [16] approximately 
20  years after the import of the first carriers. In Ger-
many, the occurrence of Weaver syndrome reached its 
peak between 1989 and 1991 with more than 20 cases 
documented by the Institute of Veterinary Pathology of 
the Ludwig-Maximilians-Universitaet (LMU) Muenchen 
in 1989 alone; the exact number is probably even larger 
because of unknown cases due to misdiagnoses and 
inconsistent reporting. Frequencies of the deleterious 
Weaver allele as high as 6.79 % in the Austrian [17] and 
6.27  % in the American Brown Swiss population [18] 
were reported. In a first attempt to limit the occurrence 
of new Weaver cases, animals with two or more affected 
progeny for which parentage verification was done by 
blood testing were excluded from further breeding. A 
genetic test for detection of carriers became available 
in 1993 when Georges et  al. [19] identified a close link 
between the Weaver locus and microsatellite TGLA116. 
In the following years, an improved indirect genetic test 
that included five additional microsatellite markers was 
developed [20]. Based on haplotypes of these six micros-
atellites that comprised two outer (RM188 and BM6458) 
and four core markers (MAF50, RM067, TGLA116 and 
BM1224), animals with an estimated risk of carrying 
the Weaver allele higher than 95  % were consequently 
excluded from breeding (Ivica Medugorac, Ingolf Russ, 
unpublished observations). The successful implemen-
tation of this strategy resulted in a steadily decreas-
ing number of Weaver-affected animals and the last 
case was diagnosed by the LMU Institute of Veterinary 
Pathology in 1997. However, the Weaver allele has not 
been completely eliminated from the population and the 
estimated frequency ranges from 3.28 to 4.01  % in the 
Austrian [21] and is about 2.6 % in the American Brown 
Swiss population [22]. In 2013, McClure et al. [23] dis-
cussed the possibility of an even higher frequency due to 
possible recombination between the Weaver locus and 
the microsatellite markers of the diagnostic test, which 
may lead to false negative results for active breeding 
animals. Thus, the frequency of the deleterious Weaver 
allele may continue to increase without being noticed 
and the occurrence of new Weaver cases would only be 
a question of time. Although the fine-mapping approach 
that was used by McClure et  al. [23] was not success-
ful in detecting the causal mutation, the Weaver locus 
was narrowed down to a 5-Mb window between 48 and 
53  Mb on BTA4 (BTA for Bos taurus chromosome), 
which led to the identification of 41 diagnostic single 
nucleotide polymorphisms (SNPs) and to the defini-
tion of a common haplotype associated with the Weaver 
phenotype. Indirect diagnosis by SNP-based imputation 
and haplotype analysis [23] suggested that in spite of the 
exclusion of high-risk breeding animals and complete 
absence of Weaver cases over the last two decades, some 
of the animals used in current breeding programs could 
be Weaver carriers. However, in some cases, in-depth 
pedigree analyses of such potential carriers did not iden-
tify any confirmed Weaver carrier ancestors, which can 
be explained by: (1) inaccurate or incomplete pedigree 
records, (2) the presence of a large number of previously 
undetected carriers in the current Braunvieh/Brown 
Swiss population, or (3) a relatively recent causal muta-
tion, thus the frequency of the original haplotype con-
taining the ancestral allele may still be high, leading to 
false positive imputation results.
The aim of this study was to identify the allele(s) that 
cause Weaver syndrome and thus to provide the basis for 
a direct gene diagnosis, effective monitoring of the genet-
ically active Braunvieh/Brown Swiss population and also 
for future studies on the exact molecular genetic mecha-
nisms that underlie this neurodegenerative disease.
Methods
Animal samples and phenotypes
In this study, we used a population that consisted of 34 
Original Braunvieh individuals and a group of 126 pure-
bred Brown Swiss and Brown Swiss  ×  Braunvieh ani-
mals. Of these 160 animals, 86 were Weaver-free, 31 
Weaver carriers and 43 Weaver-affected. Disease status 
was assigned based on neuropathological records from 
the LMU Institute of Veterinary Pathology that con-
firmed that the lesions and alterations were characteristic 
of the Weaver syndrome. Weaver carriers were identified 
by progeny-testing and required that an animal had to 
have at least two Weaver-affected offspring with proven 
ancestry to be declared an official carrier of the Weaver 
syndrome.
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Since the last case of Weaver syndrome that was 
reported in 1997, no biological samples from live 
Weaver-affected animals were available. Instead, we used 
blood and DNA samples that were available from stud-
ies performed during the late 1980s and early 1990s for 
analyses. For some cases, additional samples of formalin-
embedded spinal cord tissue and sections of the spinal 
cord that had been stored in the archives of the LMU 
Institute of Veterinary Pathology were investigated. 
Since all the samples used in the current study originated 
from previous routine tests for paternity and determin-
ing an animal’s Weaver status, ethical approval was not 
required.
Genotypes
Genotyping was performed on 43 Weaver-affected, 28 
Weaver carriers and 51 Weaver-free animals using the 
Illumina Bovine SNP50 BeadChip (Illumina, San Diego, 
USA). Data on 34 Original Braunvieh animals were also 
available from a previous research project [24]. Geno-
types of four additional animals (three Weaver carriers 
and one Weaver-free animal) were provided by Braun-
vieh Schweiz (Zug, CH). The physical positions of all 
SNPs were determined according to the UMD 3.1 Bos 
taurus reference assembly [25]. SNP call rates for all ani-
mals were higher than 0.95, thus it was not necessary to 
exclude any animals because of low genotyping success.
For further analysis, SNPs were filtered based on the 
following exclusion criteria: (1) unsuccessful genotyping 
for more than 5 % of the animals, (2) frequent paternity 
conflicts for animals with known paternity, (3) unknown 
or ambiguous map positions in the reference genome, (4) 
SNPs with a level of heterozygosity <0.05 and (5) SNPs 
located on chromosomes other than BTA4 since the 
Weaver locus has been mapped to BTA4 by Georges et al. 
[19]. After filtering, 1958 SNPs remained for analyses.
Linkage/linkage disequilibrium mapping on BTA4
In order to fine map the Weaver locus, a combined link-
age disequilibrium and linkage (cLDLA) method equiv-
alent to that proposed by Meuwissen et  al. [26] was 
applied, which allows the use of data on both confirmed 
carriers and affected animals.
First, haplotype reconstruction and imputation of 
missing genotypes were conducted using the program 
BEAGLE 3.0.4 [27], which is based on a Hidden Markov 
model and exploits the linkage information contained 
in the relationships between genotyped animals in the 
pedigree. To increase the accuracy of haplotype recon-
struction, 8153 additional animals that were otherwise 
not part of our analyses were included. The whole data-
set consisted of 168 parent–offspring trios, 3212 par-
ent–offspring pairs and 5134 unrelated animals. The 43 
Weaver-affected animals in the population used for map-
ping were divided in two categories, i.e. 22 parent–off-
spring pairs and the remaining 21 animals for which no 
genotype information on the parents was available.
To avoid an inflation of false-positive results due to 
population stratification in the final mixed linear model, 
the genome-wide unified additive relationships (UAR) 
between all animals were estimated [28]. The principal 
components of the UAR-matrix were determined in R 
[29]. The R package paran, which is an implementation of 
Horn’s parallel analysis [30], was then used to identify the 
main principal components that explain more than 90 % 
of the genetic variance. The first 60 principal components 
were integrated in the mixed linear model.
To account for local haplotype relationships and, thus, 
linkage disequilibrium, sliding windows of 40 consecu-
tive SNPs along BTA4 were used. Following the method 
described by Meuwissen and Goddard [31], the locus 
identity by descent (LocIBD) was estimated for each 
40-SNP window midpoint, i.e. between SNPs 20 and 21. 
Subsequently, the procedure suggested by Lee and Van 
der Werf [32] for additive genetic relationship matrices 
(GRM) was applied to convert the resulting LocIBD matri-
ces into diplotype relationship matrices (DRM).
Finally, a variance component analysis at the mid-
point of each of the 40-SNP sliding windows was con-
ducted using ASReml [33]. The mixed linear model was 
as follows:
where y is a n ×  1 vector of phenotypes of the investi-
gated trait. In order to map Weaver syndrome as a quan-
titative trait, phenotypes were converted into numerical 
values as follows: 1.0 for Weaver-free animals, 2.0 for 
confirmed Weaver carriers and 3.0 for Weaver-affected 
animals confirmed by pathological records. In prac-
tice, Weaver syndrome was diagnosed based on clinical 
observations in a three-step process: (1) the first clinical 
observation and diagnosis was carried out by local vet-
erinarians on the farm, (2) if the farmer agreed, clear-cut 
Weaver cases were transported to the Clinic for Rumi-
nants (LMU, Oberschleißheim) for additional clinical 
observation, and (3) the Weaver cases that were con-
firmed in step (2) were euthanized and pathologically 
examined by the Institute of Veterinary Pathology (LMU, 
Munich). Some Weaver cases were only supported by 
observations from steps (1) and (2) because final patho-
logical proof was not performed mainly because of either 
schedule difficulties, i.e. no capacities were available at 
the Institute of Veterinary Pathology on the desired date, 
or of premature death of Weaver animals identified in 
steps (1) and (2). For clinically-confirmed animals that 
lacked pathological records, we applied the following 
y = Xβ + Zq + e,
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interpolated phenotype values: 2.75 for animals with a 
confirmed carrier ancestor on both the maternal and 
paternal side of the pedigree with a maximum interval 
of two generations between them; 2.5 for animals with 
an interval of three or more generations between them-
selves and one or both carrier ancestors; 2.25 for animals 
with only one official carrier in the pedigree; and 2.0 
for animals with missing pedigree data. β is a vector of 
fixed effects that contains the overall mean µ and the 60 
principal components. Random additive genetic effects 
based on the DRM are included in q, a vector that follows 
a normal distribution, i.e. q ~ N(0, DRMp σ 2q ), where DRMp 
is the diplotype relationship matrix at position p of the 
putative quantitative trait locus (QTL), while e is a vector 
of random residual effects with e ~ N(0, I σ 2e ), where I is 
an identity matrix. X and Z are incidence matrices relat-
ing to fixed and random QTL effects. Both vectors q and 
e are assumed to be uncorrelated and have a normal dis-
tribution with mean 0 and variance σ 2q  and σ 2e .
For each 40-SNP window, ASReml simultaneously esti-
mates the maximum log-likelihood, variance components 
and the fixed and random effects by taking into consider-
ation the IBD probabilities of a putative QTL at the win-
dow midpoint. To compare the resulting log-likelihoods 
of the model assuming a QTL (alternative hypothesis, 
H1) with a model excluding a QTL at this location (null 
hypothesis, H0), a likelihood ratio test statistic (LRT) was 
used. It was calculated as follows:
and shows a Chi square distribution with one degree of 
freedom [34]. The SNP window for which the difference 
between both likelihoods reaches its maximum is most 
likely to harbor the QTL.
In order to maintain the rate of false discoveries (type 
I errors) at a low level, a rather conservative significance 
threshold was chosen, i.e. LRT  =  25.223, which cor-
responds to a Bonferroni-corrected P value of less than 
5.11 × 10−7 (0.001/1958 = 5.11 × 10−7). For peaks with 
a LRT higher than 25.223, confidence intervals (CI) were 
determined by the 2-LOD drop-off method (1 LOD (log 
of odds) = 4.605) [35, 36]. The identified region was then 
compared with a map of annotated genes to identify pos-
sible candidate genes.
Homozygosity mapping and identification of a common 
haplotype on BTA4
In order to compare the cLDLA method with classical 
homozygosity mapping, the same Weaver-affected and 
Weaver-free animals that were included in the cLDLA 
approach were used in a case–control design following 
the ASSHOM procedure in Charlier et al. [37]. In a paral-
lel approach, genotypes of a subset of 31 carrier animals 
LRT = −2×
(
log likelihood(H0)− log likelihood(H1)
)
,
(progeny-confirmed) and 13 Weaver-affected direct off-
spring (status confirmed by pathological records and 
with at least one genotyped parent) were manually ana-
lyzed, which led us to identify a common haplotype that 
was compared to the interval detected by homozygosity 
mapping.
Exploiting whole‑genome sequence data for the 
identification of candidate causal mutations
Sequence data from Run4 of the 1000 bull genomes 
project [38] were exploited to identify candidate causal 
mutations for Weaver syndrome in Braunvieh cat-
tle. The Run4 data consist of full sequence information 
for 1147 animals that represent 29 breeds including 
59 Braunvieh animals. Two known Weaver carriers 
(TARGET-BSWUSAM000000174360 and MODERN-
BSWUSAM000000156458) are among the sequenced 
Braunvieh animals. All sequence variants (SNPs, short 
insertions and deletions) located within the 1.72-Mb 
segment (between 48,688,283 and 50,412,884  bp) of 
extended homozygosity were considered for the iden-
tification of candidate causal mutations. Those muta-
tions were filtered for variants for which the two known 
Weaver carriers were heterozygous, while all other ani-
mals were homozygous for the reference allele.
Targeted SNP genotyping by PCR‑RFLP
The candidate SNP (rs800397662) on BTA4 at posi-
tion 49,878,773  bp was analyzed by PCR-RFLP on 103 
animals (40 Weaver-affected and 63 Weaver carri-
ers) for which DNA samples (that had been prepared 
in the late 1980s and early 1990s) were still available. 
The DNA segment containing the candidate muta-
tion was amplified by PCR using the following primers 
5′-CAAAGGCTTTTGGCGTTATC-3′ and 5′-GCAAA-
CAGAAGCAGATCCTTTT-3′ and subsequently treated 
with the site-specific restriction enzyme RsaI. Fragments 
were separated according to size and visualized by 2  % 
ethidium bromide-stained agarose gel electrophoresis.
For the second variant (rs442854880) that was associ-
ated with the Weaver status based on whole-genome 
sequence data but was located outside the segment of 
extended homozygosity at Chr4:50,858,538 bp, the same 
procedure was applied on samples of 16 Weaver-affected 
animals and 30 confirmed carriers (restriction enzyme 
RsaI, primers 5-GATCGAGCAGCTGAAAAAGG-3′ and 
5′- AAGTCACCATGGGAAACCTG-3′).
Pathological re‑evaluation of animals with conflicting 
PCR‑RFLP results
For animals that showed discrepancies between the 
anticipated disease status and the genotyping results, his-
topathological sections of the spinal cord which had been 
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kept in the archive of the LMU Institute of Veterinary 
Pathology were re-evaluated. If embedded spinal cord 
tissue was also available, additional hematoxylin–eosin-
stained sections were prepared. These sections were then 
evaluated by an experienced veterinary neuropathologist 
in the light of the latest scientific knowledge.
Results
Linkage/linkage disequilibrium mapping on BTA4
On BTA4, LRT values exceeding the significance thresh-
old of 25.223 were detected between SNPs at positions 
46,172,128 and 54,324,740 bp, which indicated an associ-
ation between this region and the occurrence of Weaver 
syndrome. The peak reached its maximum (LRT = 73.9) 
at position 49,812,384 bp and the boundaries of its con-
fidence interval (CI) that were determined by the 2-LOD 
drop-off method were set at positions 49,514,652 and 
50,367,484 bp (Fig. 1a). According to the Ensembl data-
base [39], the following genes are located within this CI: 
NRCAM, PNPLA8, NME8, SFRP4, EPDR1, STARD3NL, 
the novel microRNA genes ENSBTAG00000045095 and 
ENSBTAG00000044255 and the uncharacterized pro-
tein coding genes ENSBTAG00000014795 and ENS-
BTAG00000035945 (Fig. 1b).
A second peak (LRT  =  61.835) was detected out-
side of this first CI but in close proximity at position 
47,598,264 bp. The boundaries of the CI of this sec-
ondary peak that were determined as above were set at 
positions 47,343,868 and 47,750,208  bp, which resulted 
in a 0.4-Mb CI that was found to harbor the follow-
ing genes [39]: CDHR3, SYPL1, NAMPT, the micro-
RNA gene ENSBTAG00000044548, the U6 snRNA 
gene ENSBTAG00000042539 and the pseudogene 
ENSBTAG00000019824.
Homozygosity mapping and identification of a common 
haplotype on BTA4
Homozygosity mapping using the complete set of Weaver 
cases from the cLDLA approach did not provide the 
expected results. It was necessary to exclude some ani-
mals which, upon re-examination, in fact were phe-
nocopies, to successfully map the Weaver locus within a 
1.913-Mb block of adjacent SNPs (between 48,408,626 
and 50,412,884 bp) for which all remaining animals were 
homozygous (see Additional file 1: Figure S1). This inter-
val was concordant with the common haplotype that was 
identified in parallel by manually scanning genotypes of 
affected animals (confirmed by all three diagnostic steps) 
for regions of homozygosity surrounding the main and 
secondary LRT peak on BTA4. By aligning the haplotypes 
of all progeny-tested Weaver carriers, the common hap-
lotype was reduced to a region between SNPs at posi-
tions 48,688,283 and 50,412,884 bp. All Weaver-affected 
animals were homozygous at this 37-SNP haplotype, 
whereas animals designated as Weaver carriers carried 
only one copy of the haplotype. Furthermore, this haplo-
type analysis clearly excluded the above-mentioned sec-
ondary peak as a positional candidate region for Weaver 
syndrome (see Additional file 2: Figure S2).
Exploiting whole‑genome sequence data for the 
identification of candidate causal mutations
We considered 22,160 sequence variants (21,151 SNPs 
and 1009 indels) that were located within the 1.72-Mb 
segment (between 48,688,283 and 50,412,884  bp) of 
extended homozygosity as positional candidate causal 
variants. Among these, only one variant, rs800397662 
(Chr4:49,878,773  bp), was heterozygous in the two 
known Weaver carriers, while all other 1145 animals 
from 29 breeds were homozygous for the reference allele 
(see Additional file 3: Table S1). This only compatible var-
iant is a missense mutation (p.S568N, c.G1703A) in the 
PNPLA8 gene that encodes patatin-like phospholipase 
domain containing 8 (Fig.  1c, d). This p.S568N variant 
is predicted to be highly damaging to protein function 
(SIFT-score [40]: 0.01, Polyphen2-score [41]: 1.00). A 
serine residue at position 568 of PNPLA8 is conserved 
throughout eukaryotes, which suggests that it is essential 
for normal protein function (Fig. 2).
Furthermore, a second variant (rs442854880) which 
was also exclusively heterozygous in the two known 
Weaver carriers and homozygous for the reference allele 
in all other sequenced animals was detected outside of, 
but in close proximity to, the region of extended homozy-
gosity at position Chr4:50,858,538 bp.
Targeted PCR‑RFLP genotyping for SNP 
Chr4:49,878,773 bp (rs800397662)
The results of the PCR-RFLP assay agreed with the theory 
of a causative mutation at position 49,878,773  bp since 
carrier animals were heterozygous and affected animals 
were homozygous for the alternative allele, while Weaver-
free animals were homozygous for the reference allele.
We observed conflicts for four Weaver-affected ani-
mals with pathological records and one Weaver carrier 
whose status had been determined only on the basis of 
the indirect microsatellite test (Table  1). Three of the 
affected animals were tested heterozygous (CT), while 
one affected animal and the carrier were tested homozy-
gous (CC) for the reference allele of the SNP at position 
49,878,773 bp.
Targeted PCR‑RFLP genotyping for SNP 
Chr4:50,858,538 bp (rs442854880)
The results of the PCR-RFLP assay for the second can-
didate causal mutation at Chr4:50,858,538  bp, which 
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is located outside the 1.72-Mb segment of extended 
homozygosity, showed that among the 30 progeny-con-
firmed Weaver carriers, all animals except one (W0037) 
were heterozygous at this SNP (GA) (Table  2). Animal 
W0037 is the dam of one pathologically-confirmed 
Weaver-affected animal although it is homozygous for 
the alternative allele A. Genotyping of the 16 Weaver-
affected animals showed that they were all homozygous 
for the alternative allele (AA) except animal W0246 
(Table  2) which was heterozygous (GA) at the SNP at 
Chr4:50,858,538 bp and for the region surrounding this 
SNP.
Re‑evaluation of pathological and pedigree records 
of animals with conflicting PCR‑RFLP results
It should be noted that this study investigated tissues and 
histopathological sections that were collected and pre-
pared over 20 years ago. For animals W0068, W0084 and 
W0125 (Table  1), neither histopathological sections nor 
embedded spinal cord tissue were stored in the archive of 
the LMU Institute of Veterinary Pathology. Records and 
pedigree data from a previous project on Weaver syn-
drome revealed that there were already serious doubts 
about the animals’ disease status at the time of collection. 
(See figure on previous page.) 
Fig. 1 Identification of a candidate causal mutation at position 49,878,773 bp on BTA4. a Results of the combined linkage/linkage disequilibrium 
mapping approach. Colored dots indicate the positions of the six microsatellite markers (RM188, MAF50, RM067, TGLA116, BM1224, BM6458) of the 
indirect genetic test for Weaver syndrome. A maximum peak value (LRT = 73.9) was detected between microsatellite markers RM188 and MAF50 
at position 49,812,384 bp. The 2-LOD drop-off method used to determine the corresponding confidence interval sets its boundaries at positions 
49,514,652 and 50,367,484 bp. b Detailed overview of the confidence interval between 49,514,652 and 50,367,484 bp. Six genes (NRCAM, PNPLA8, 
NME8, SFRP4, EPDR1, STARD3NL), two novel microRNA genes (ENSBTAG00000045095, ENSBTAG00000044255) and two uncharacterized protein cod-
ing genes (ENSBTAG00000014795 and ENSBTAG00000035945) are located within this confidence interval. The vertical blue line indicates the position 
of the maximum peak value (LRT = 73.9, 49,812,384 bp). The vertical red line indicates the position of the candidate causal mutation at position 
49,878,773 bp (rs800397662), which was identified by analyzing whole-genome sequence data. c Detailed structure of the PNPLA8 gene that car-
ries the candidate causal mutation. Bold sections represent exons, thin sections represent introns. The vertical red line indicates the position of the 
candidate causal mutation. d The 41-bp DNA sequence that harbors the candidate causal mutation. Red letters between brackets represent the SNP 
at position 49,878,773 bp (C: reference allele, T: alternative allele)
H. sapiens (human) 550  MIETARNPTCPKVAAVSTIVNRGITPKAFVFRNYGHFPGINSHYLGGCQY   599  
P. troglodytes (chimpanzee) 550  MIETARNPTCPKVAAVSTIVNRGITPKAFVFRNYGHFPGINSHYLGGCQY   599  
M. mulatta (Rhesus monkey) 550  MIETARNPTCPKVAAVSTIVNRGITPKAFVFRNYGHFPGNNSHYLGGCQY   599  
C. lupus familiaris (dog) 552  MIETARNPSCPKVAAVSTIVNRGITPKAFVFRNYGHFPGINSHYLGGCQY   601  
B. taurus (domestic cow) 552  MIETARNPKCPKVAAVSTIVNRGITPKAFVFRNYGHFPGINSHYLGGCQY   601  
M. musculus (house mouse) 544  MIETARNPACPKVAAISTIVNRGQTPKAFVFRNYGHFPGTNSHYLGGCQY   593  
R. norvegicus (common rat) 544  MIETARDPLCPKVAAVSTIVNRGQTPKAFVFRNYGHFPGTNSHYLGGCQY   593  
G. gallus (chicken)  571 MIETARNSKCPKVAAVSTIVNRGTPLKAFVFRNYNHFPGVKSHYIGGCQY   620  
D. rerio (zebrafish)  463 MVETSKNPNCPKVSAVSTVVNRGLPLKAYVFRNYNFLPGVRSHYLGSCQH   512  
A. gambiae (African malaria mosquito) 200  IIDTVMLPNVPKFCCISTTVCDEY-IDAHVFRNYTFPQNVQSVYAGSHTA   248  
C. elegans (threadworm)  316  MINTSRKLHTPRLAIVSSIVNLPT-IQPYIFRNYDHPAGRDSHYRGGADH   364  
X. tropicalis (western clawed frog) 544  MVETARNPLCPKVSAVSTIVNRGMPLKAFVFRNYNHFPGIKSPYMGGCQY   593  
Fig. 2 Multi-species alignment of the PNPLA8 protein sequence. The red bar highlights the serine residue at position 568 of PNPLA8 which is 
conserved throughout eukaryotes. The grey bar highlights the Bos taurus reference sequence. (NCBI HomoloGene, http://www.ncbi.nlm.nih.gov/
homologene, Accessed 25 Aug 2015)
Table 1 Conflicts between  clinical/genetic diagnosis 
and targeted genotyping for the SNP Chr4:49,878,773 bp
Capital letters represent the animals’ genotypes (SNP_49878773 genotypes: C: 
reference allele, T: alternative allele; additional information on SNP_50858538 
genotypes: G: reference allele, A: alternative allele). MS test: indirect genetic 
test for Weaver syndrome based on six microsatellite markers (RM188, MAF50, 
RM067, TGLA116, BM1224, BM6458); animals with an estimated risk of ≥95 % of 
carrying the Weaver allele were declared as carriers and excluded from further 
breeding







W0045 Affected CT GA
W0068 Affected CT GA
W0084 Affected CC GG
W0125 Affected CT AA
W0226 Carrier (MS test) CC GG
Table 2 Comparison between  clinical/genetic diagnosis 
and targeted genotyping for the SNP Chr4:50,858,538 bp
Capital letters represent the animals’ genotypes (additional information 
on SNP_49878773 genotypes: C: reference allele, T: alternative allele; 
SNP_50858538 genotypes: G: reference allele, A: alternative allele)





W0037 Carrier CT AA
W0246 Affected TT GA
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For these three animals, confirmed Weaver carriers were 
missing on one or both sides of the pedigree, which indi-
cates that Weaver syndrome had been incorrectly diag-
nosed. We also assumed a false positive result for sire 
W0226 whose carrier status had been determined by the 
commercial microsatellite test although there were no 
reports of Weaver cases among its offspring [42].
For animal W0045, embedded spinal cord tissue was 
still available, thus newly prepared sections were evalu-
ated by the Institute of Veterinary Pathology and con-
firmed the anticipated disease status as Weaver-affected. 
However, this did not agree with the results of the PCR-
RFLP assay that showed that it was heterozygous (CT). 
Reassessment of familial relationships revealed that this 
animal was born as a twin, which raised the possibil-
ity of blood chimerism. Blood chimerism describes the 
coexistence of blood cell lines with two different geno-
types in one organism [43] and is a phenomenon often 
observed in twin cattle [44]. DNA for animal W0045 
was extracted from blood, which was the only avail-
able tissue, and was genotyped twice with Illumina’s 
BovineSNP50 BeadChip. Low call rates of 0.95 and 0.96, 
respectively, were obtained which is typical of chimeric 
individuals [45]. In order to genotype samples for the 
candidate SNP at position 49,878,773  bp (rs800397662) 
more efficiently, a specifically designed KASPar™ Geno-
typing System (LGC, Teddington, UK) was used. The 
KASP assay [46] is known for its high correlation (aver-
age r =  0.9796 ±  0.0094) between relative allele dosage 
and the difference in observed signal strength [47]. Com-
parison of the KASP signal intensities of 39 confirmed 
Weaver carriers and animal W0045 revealed significant 
differences. While signal intensities were relatively simi-
lar for both alleles (C: 4478.84 and T: 4654.28) for all 
Weaver carriers, the intensity of the reference allele for 
animal W0045 was significantly weaker (C: 2605.50) than 
that of the alternative allele (T: 6412.00).
For animals W0037 and W0246, for which controver-
sial results were found in targeted genotyping for the 
SNP at position 50,858,538 bp (rs442854880), it was not 
possible to perform a histopathological reassessment 
because no spinal cord tissue was available. Pedigree 
records revealed that animal W0037, which was homozy-
gous for the alternative allele, had given birth to a calf at 
the age of 38 months. Since the first symptoms of Weaver 
syndrome usually appear between 5 and 8 months of age 
[6], i.e. before the onset of sexual maturity, the alterna-
tive allele at 50,858,538  bp was excluded as a candidate 
causal mutation. This exclusion was further supported 
by the genotyping results for animal W0246 which was 
homozygous for the reference allele, while all available 
pedigree and pathological records confirmed its status as 
a Weaver-affected animal.
Estimation of the frequency of SNP Chr4:49,878,773 bp in a 
random sample of 2334 current Braunvieh animals
A customized version of the BovineSNP50 genotyping array 
was developed to test genotypes for several relevant muta-
tions in the German and Austrian cattle populations includ-
ing the mutation at Chr4:49,878,773 bp (rs800397662). The 
frequency of the T allele at SNP Chr4:49,878,773  bp was 
equal to 0.26  % in 2334 Braunvieh animals born between 
2013 and 2015 that had been genotyped with this custom 
array since January 2014 (Table 3). For the remaining 12,197 
animals from different breeds, the T allele was not detected.
Targeted genotyping on a random sample of animals 
from other breeds that carry the Weaver haplotype
The genotyping results with the custom chip clearly dem-
onstrated the absence of the only remaining and most 
likely candidate causal mutation for Weaver syndrome 
in 12,197 non-Braunvieh animals. To further demon-
strate that this mutation is also absent in carriers of the 
Weaver haplotype from other breeds, we scanned haplo-
types of several non-Braunvieh animals in the Bavarian 
and Swiss databases and found six animals that carried 
the Weaver haplotype and for which samples could be 
easily obtained for targeted genotyping, i.e. four Fleck-
vieh, one Swiss Simmental and one Holstein. All six 
animals were homozygous for the reference C allele at 
Chr4:49,878,773  bp, thus an association between the 
Weaver haplotype and the most promising candidate 
causal mutation across breeds was excluded.
Re‑assessing the carrier status of the controversial Weaver 
carrier W0277
Animal W0277 (Table  4), which was sired by one of 
the most prominent Weaver carrier bulls in Germany 
(W0380), was itself a successful AI sire with 11,398 
daughters in milk production in Germany [48] and about 
the same number of sons including 14 proven sires [49]. 
In the 1990s, indirect genetic testing and risk analysis 
based on six microsatellite markers and the resulting hap-
lotypes declared that animal W0277 was a Weaver car-
rier. This finding did not agree with the high frequency of 
the Weaver allele observed in the Braunvieh population 
Table 3 Estimation of  the frequency of  the mutation 
in PNPLA8 in current Braunvieh/Brown Swiss animals
Number of genotyped bulls according to year of birth (November 2015)







2013 122 2 0.82
2014 834 3 0.18
2015 1378 7 0.25
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[17, 18] and with the large number of unsuspicious 
W0277 offspring at that time. Consequently, this result 
was questioned by some breeders and breeding organiza-
tions. However, it is only after testing animal W0277 as 
a Weaver carrier that two direct offspring (W0165 and 
W0364) and one granddaughter (W0289) were identified 
as Weaver-affected animals on the basis of clinical symp-
toms and subsequent histopathological examination of 
relevant tissues.
These findings on the suspected carrier bull W0277 
and its three offspring challenged our analyses. In order 
to clarify the carrier status of W0277 and eliminate any 
uncertainty with respect to the small number of affected 
offspring, samples from this bull, three of its progeny 
and their corresponding dams were also analyzed in our 
study. Hematoxylin–eosin-stained histological sections 
of the spinal cord at three different levels (lumbar, tho-
racic and cervical sections of the spinal cord) were re-
evaluated by the LMU Institute of Veterinary Pathology 
in the light of the latest scientific knowledge. In a parallel 
approach, BovineSNP50 and PCR-RFLP genotypes were 
collected using available DNA samples of W0277 and its 
relatives (Table 4).
Neuropathological re-evaluation of histological sec-
tions showed atypically-located lesions in the dorsal part 
of the spinal cord or the grey matter, edematous altera-
tions and inflammation. These findings pointed more 
towards spinal cord infarction or segmental damage 
through trauma rather than towards true cases of Weaver 
syndrome. In addition, no common type and distribution 
pattern of the lesions were identified.
The results of the PCR-RFLP assay for SNP 
Chr4:49,878,773 bp showed that the affected progeny, their 
respective dams and the W0277 bull were homozygous for 
the reference allele, which did not match with their assumed 
disease status. Only the sire of the affected granddaugh-
ter was heterozygous, which agreed with its carrier status 
(Table 4). Moreover, the absence of the Weaver haplotype in 
the W0277 family confirmed these findings (Fig. 3).
Subsequent homozygosity mapping of the three 
W0277 offspring against a set of 46 healthy Brown 
Swiss and 34 Original Braunvieh animals revealed only 
three relatively short haplotypes (that contained five 
or six consecutive SNPs) for which all three W0277 
offspring were exclusively homozygous. These hap-
lotypes were located on BTA1 (between 139,231,307 
and 139,409,122  bp), BTA5 (between 10,560,048 and 
10,788,597  bp) and BTA16 (between 62,134,743 and 
62,361,331  bp). Comparison of the DNA sequences of 
each of these chromosomal segments between animal 
W0277 and its Weaver carrier sire did not identify any 
known mutation that may cause a fatal recessive disor-
der based on current knowledge. Therefore, all three 
W0277 offspring represent phenocopies and are char-
acterized by the absence of any common genetic or 
phenotypic feature.
Discussion
Combined linkage/linkage disequilibrium mapping 
on BTA4 resulted in a log-likelihood peak at position 
49,812,384 bp (Fig. 1a). The corresponding CI (between 
49,514,652 and 50,367,484  bp) contained two genes 
that were previously discussed by McClure et al. [23] as 
two of the most likely candidate genes for Weaver syn-
drome: NRCAM and PNPLA8, with PNPLA8 being more 
closely located to the position of the maximum LRT 
value (Fig. 1b). Although gene products of NRCAM play 
important roles in neuronal development and function 
[35, 50–54], this gene was excluded as a potential candi-
date following the results presented here.
Table 4 Familial relationships, genotypes and assumed disease status of animal W0277, its progeny and their dams
SNP_49878773 genotypes: C: reference allele, T: alternative allele; SNP_50858538 genotypes: G: reference allele, A: alternative allele, dashes indicate that the animal 
was not genotyped due to the lack of testing material. Clinical re-evaluation in 2015: dashes indicate the lack of embedded spinal cord tissue and histopathological 
sections








W0277 Sire of W0165 and W0364, maternal 
grandsire of W0289
Carrier – CC GG
W0165 Direct offspring Affected Free CC GA
W0166 Dam of W0165 Carrier – CC –
W0364 Direct offspring Affected Free CC GG
W0365 Dam of W0364 Carrier – CC GG
W0289 Granddaughter of W0277 Affected Free CC –
W0287 Dam of W0289, daughter of W0277 Carrier – CC –
W0303 Sire of W0289 Carrier – CT GG
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Furthermore, a common homozygous haplotype that 
was shared by all Weaver cases was identified. The 1.72-
Mb segment (between 48,688,283 and 50,412,884  bp), 
which overlapped with the diagnostic haplotype that 
had been suggested by McClure et al. [23] and the CI of 
the main peak along its entire length, excluded the sec-
ondary peak that was detected at position 47,598,264  bp 
(LRT = 61.835) (see Fig. 1a, Additional file 1: Figure S1). 
Of the two candidate mutations that were identified by 
analyzing whole-genome sequence data from the 1000 
bull genomes project [38], the non-synonymous SNP at 
position 49,878,773  bp (rs800397662) in PNPLA8 was 
included in the 1.72-Mb segment of extended homozy-
gosity (Fig. 1b), while the second mutation (rs442854880) 
was located close to the haplotype’s distal border at posi-
tion 50,858,538 bp in CTTNBP2. Both mutations were also 
on a list of SNPs located between 48 and 53 Mb on BTA4 
which had been suggested as candidate causal variants by 
McClure et  al. [23] in 2013. Considering the expression 
pattern and biological functions of the corresponding gene 
products, they had concluded that the SNP in PNPLA8 
was one of the most likely variants involved in Weaver 
syndrome [23]. Targeted SNP genotyping by PCR-RFLP 
revealed conflicting results for both mutations (Tables  1, 
2). However, for the mutation at position 49,878,773  bp, 
the conflicts could be resolved by analyses of pathologi-
cal records, pedigrees and genotypes that supported the 
hypothesis of phenocopies and by the detection of blood 
chimerism. Equivalent analyses for the SNP at 50,858,538 
bp led to its exclusion as a candidate causal mutation.
Overall, the results of our analyses largely agree with 
the findings of McClure et al. [23] and are in favor of the 
non-synonymous SNP at 49,878,773  bp (rs800397662) 
as the most likely candidate causal mutation for Weaver 
syndrome. Similarities between the symptoms that are 
observed for this disease and the biological processes that 
are affected by knock-out of PNPLA8 further support this 
theory. PNPLA8 encodes calcium-independent phospho-
lipase A2γ (iPLA2γ), which is a member of the phospho-
lipase A2 family. These enzymes catalyze the hydrolytic 
cleavage of membrane glycerophospholipids at the sn-2 
position into free fatty acids and lysophospholipids which 
can be further converted to various biologically active 

















Fig. 3 Familial relationships, genotypes and haplotype structure of animal W0277 and its progeny. Haplotypes in red represent the common 
Weaver haplotype identified by homozygosity mapping (48,688,283–50,412,884 bp), haplotypes in green represent the haplotype that was passed 
down from animal W0380 to W0277 and inherited by its progeny and haplotypes in grey represent all haplotypes that were inherited from non-
carrier and non-affected ancestors. Letters in rectangles represent the animals’ genotypes for the SNP at position 49,878,773 bp (rs800397662) with C 
as the reference allele and T as the alternative allele
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iPLA2γ is linked to the release of arachidonic acid and the 
production of several eicosanoids and lysolipids involved 
in mitochondrial bioenergetics and signaling [56]. 
In  vitro analyses of rabbit renal proximal tubular cells 
with suppressed expression of iPLA2γ revealed increased 
lipid peroxidation and apoptosis, suggesting a critical role 
of the enzyme in the protection of cells against oxidative 
stress and the subsequent repair processes [51]. Simi-
lar results were observed in iPLA2γ-/- mice that showed 
impaired mitochondrial function [53, 57] and increased 
levels of oxidative stress [57] leading to progressive loss 
of muscular function and a phenotype displaying bioen-
ergetic dysfunction [53]. In humans, a case of compound 
heterozygosity for two frameshift mutations in PNPLA8 
was published recently [58]. The affected patient suf-
fered from progressive muscle weakness, gait abnormali-
ties and other neurodegenerative symptoms which were 
absent at birth but became apparent during the first years 
of infancy. Analyses revealed a lack of iPLA2γ in the mus-
cle, ultrastructural abnormalities in the mitochondria 
and a general resemblance with symptoms observed in 
the above-mentioned iPLA2γ-/- mice, which suggests that 
there is a link between the patient’s phenotype and the 
mutations in PNPLA8 [58].
Based on our assumption that the SNP in PNPLA8 
(rs800397662) is the causal mutation, the disease status 
of a controversial carrier bull and its progeny, that were 
diagnosed as Weaver-affected animals but were homozy-
gous for the reference allele, was re-evaluated. The results 
of the histopathological examination of sections of the 
spinal cord of three of its progeny disagreed with the 
original diagnosis (Table  4), which suggested that they 
were in fact phenocopies which had been misdiagnosed 
under the pressure to identify and eliminate all possi-
ble Weaver carriers from breeding during the late 1980s 
and early 1990s. However, their high degree of relation-
ship (Fig. 3) was both interesting and challenging and led 
us to put forward the following hypotheses: (1) all three 
phenocopies are the result of a different heritable disease 
which needs to be further clarified; or (2) all three phe-
nocopies are induced by a non-genetic cause. Regardless 
of the scenario, animal W0277 was incorrectly assigned 
a carrier status. Since we did not identify any common 
histopathological pattern, i.e. we observed three pat-
terns that all differed from the typical Weaver diagnosis 
and were better explained by infarctious damage and/or 
trauma to the spinal cord, the theory of another heritable 
disease that mimics Weaver syndrome was discarded. In 
addition, homozygosity mapping against a control popu-
lation of healthy individuals and comparison of the inter-
vals identified with whole-genome sequence data from 
animal W0277 did not lead to any obvious candidate var-
iants, which supports the conclusion that a second muta-
tion or an unknown genetic disease in the investigated 
family of W0277 is rather unlikely.
Our study greatly benefited from the availability of pre-
served spinal cord tissue, pathological records and a large 
number of blood and DNA samples, especially from ani-
mals affected by Weaver syndrome. As a result, we were 
able to detect the above-mentioned phenocopies which 
had been misdiagnosed in the 1990s and which may also 
explain why none of our earlier mapping attempts were 
successful. It is only through the combination of exhaus-
tive sequencing data, linkage/linkage disequilibrium 
mapping and histopathological examination that we were 
able to provide supporting evidence that the non-synon-
ymous mutation at position 49,878,773 bp (rs800397662) 
in PNPLA8 is the only remaining and most likely candi-
date causal mutation for Weaver syndrome. Our results 
further demonstrate several advantages of the cLDLA 
approach over conventional homozygosity mapping, with 
the most important being that cLDLA can exploit infor-
mation that is contributed by confirmed carriers and tol-
erate the presence of phenocopies in the mapping design. 
Moreover, there is a significant difference in mapping 
resolution between both methods, i.e. cLDLA is more 
precise even after excluding the phenocopies from the 
homozygosity mapping design (see Additional file 1: Fig-
ure S1).
Monitoring of the presumed causal mutation within a 
sample of current Braunvieh/Brown Swiss candidates for 
genomic selection shows that in spite of its low frequency 
in the genetically active part of the population (0.26  %; 
Table 3), it is still present. Among the 12 new Weaver car-
riers that were detected with the customized chip, two 
could have been selected as AI bulls based on their high 
genomic breeding values if they had not been tested for 
Weaver syndrome. Consequently, although the probabil-
ity that two carriers mate and produce affected offspring 
is much lower (approximately one out of ~605,000) than 
previously anticipated [22], this mutation still remains an 
important monitoring criterion of the population using 
the custom chip. It can also be assumed that over the last 
two decades, not all affected animals were detected and 
reported. Speaking from our general experience, reporting 
discipline strongly depends on the breeders’ current level 
of education and sensitization on a certain disease, which, 
in the case of the Weaver syndrome, is probably very low 
since many breeders and veterinarians may currently not 
be able to recognize a case of Weaver syndrome.
Although the common haplotype was detected in 
other breeds, such as the Fleckvieh and Holstein breeds, 
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at a very low frequency (0.004 in Fleckvieh and 0.001 
in Holstein), targeted genotyping showed that the can-
didate causal mutation is not present in these breeds. 
Consequently, scanning populations for the common 
haplotype is not sufficient for Weaver diagnosis and 
needs to be complemented by other analyses. Accord-
ing to the cumulative evidence of previous research, 
this might be a general rule that is also valid for other 
monogenic phenotypes that segregate in small domestic 
breeds.
From a breeding point of view, most of the questions 
regarding this recessive disorder have found answers with 
the findings of our study and previous ones. Neverthe-
less, basic issues transcending the species and regarding 
an in-depth understanding of the cellular and molecular 
genetic mechanisms involved in this progressive neu-
rodegenerative disease still remain. To fully explain the 
link between the altered PNPLA8 gene product and the 
symptoms observed in Weaver-affected animals and thus 
further confirm the causal character of this mutation, 
additional research on the cellular mechanisms that are 
involved is necessary. For this purpose, there are several 
possibilities including state-of-the-art analyses of old 
paraffin-embedded tissue samples, in  vitro gene editing 
and, if close monitoring of risk matings that involve the 
carriers detected here revealed any current Weaver cases, 
examination of live Weaver-affected animals.
Conclusions
Based on the results of both McClure et  al. [23] and 
our studies, the non-synonymous SNP in PNPLA8 
(rs800397662, 49,878,773  bp) is most likely the causative 
mutation that underlies Weaver syndrome. The perfect 
association between this SNP that was detected by whole-
genome sequencing, different mapping and genotyping 
approaches and the cellular functions of the PNPLA8 gene 
products highly supports this conclusion. Estimation of 
allele frequency in a sample of current Braunvieh/Brown 
Swiss animals for the time span between 2013 and 2015 
resulted in a low value of 0.26 %. With a very low expected 
risk of random carrier–carrier mating (0.0000066), the 
occurrence of new Weaver cases after more than 20 years 
of complete absence of case reports seems rather unlikely 
but corresponds to approximately one case per 605,000 
animals, i.e. at most one Weaver case per year in the cur-
rent German-Austrian Braunvieh cow population. The 
presence of the Weaver haplotype alone is not sufficient 
for an indirect diagnosis neither in the Braunvieh/Brown 
Swiss breed nor in any other cattle breed. Future research 
on the cellular mechanisms that are altered by this non-
synonymous mutation in PNPLA8 is needed to further 
prove its causal character and thus enhance our under-
standing of the cellular functions that are involved in 
Weaver syndrome and similar neurodegenerative diseases 
in various species including humans.
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Additional files
Additional file 1: Figure S1. Comparison of the results of cLDLA map-
ping with the results of case–control homozygosity mapping. The blue 
line with blue dots represents the results of the cLDLA mapping approach 
using data on 43 Weaver-affected, 31 Weaver carriers and 86 Weaver-free 
animals which resulted in a maximum LRT value (LRT = 73.9) at position 
49,812,384 bp. The corresponding 0.853-Mb confidence interval between 
SNPs at 49,514,652 and 50,367,484 bp, represented by the grey bar, is 
assumed to harbor the causative mutation. The black line with black 
squares represents the results of a case–control homozygosity mapping 
approach [37] based on all Weaver-affected (case group) and Weaver-
free animals (control group) from the cLDLA mapping population. In a 
second run, all Weaver cases which had been identified as phenocopies 
in the course of our further analyses were removed from the case group. 
The results of this run are displayed by the red line with red squares. 
Only run 2 of the homozygosity mapping approach, i.e. after removal 
of the phenocopies which were identified later, displayed a significant 
association with a 1.913-Mb block of adjacent SNPs (between 48,408,626 
and 50,412,884 bp). However, the cLDLA approach was able to map the 
Weaver locus to the same chromosomal region even if the phenocopies 
were still included in the mapping population. Furthermore, the 0.853-Mb 
confidence interval identified by the cLDLA method allows for more pre-
cise analyses than the 1.913-Mb block of SNPs identified by homozygosity 
mapping, accounting for the higher mapping resolution obtained by the 
cLDLA method.
Additional file 2: Figure S2. Identification of a common haplotype on 
BTA4. Description: Genotypes of a subset of 32 Weaver carriers and 13 
Weaver-affected offspring were scanned for regions of homozygosity 
surrounding the main and secondary peaks. The segment of interest 
consisted of 197 SNPs between positions 44,387,787 and 47,598,264 bp. 
Carets (^) indicate the position of the secondary peak (47,598,264 bp), 
asterisks (*) indicate the position of the main peak (49,812,384 bp). Red 
bars indicate shared haplotype segments, green bars indicate the com-
mon haplotype shared by both Weaver-affected and carrier animals.
Additional file 3: Table S1. Genotype distribution of 41 candidate 
causal mutations for Weaver syndrome in 1147 animals. The distribution 
of the genotypes of 41 candidate causal mutations (McClure et al. [23]) 
for Weaver syndrome in 1147 animals sequenced in the course of the 
1000 bull genomes project was analyzed. The sequenced animals were 
grouped by breed. Numbers represent the within-breed frequency of the 
alternative allele. The distribution of genotypes for each breed is given in 
parentheses (homozygous animals for the reference allele | heterozygous 
animals | homozygous animals for the alternative allele). The grey back-
ground indicates candidate causal variations within the 1.72-Mb segment 
of extended homozygosity. Blue color indicates two variants that were 
perfectly associated with the Weaver status of 1147 sequenced animals. 
However, only one compatible variant (rs800397662, Chr4:49,878,773 bp) 
is located within the segment of extended homozygosity.
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